Olux-E Approval History 
- FDA approved: Yes (First approved January 12th, 2007)
- Brand name: Olux-E
- Generic name: clobetasol propionate
- Company: Stiefel Laboratories, Inc.
- Treatment for: Psoriasis, Eczema
Olux-E (clobetasol propionate) is a topical steroid formulated in VersaFoam emulsion foam drug delivery vehicle indicated for the treatment of psoriasis and eczema in patients 12 years of age or older.
FDA Approval History for Olux-E
| Date | Article |
|---|---|
| Jan 12, 2007 |  Olux-E Stiefel Laboratories, Inc. - Treatment for Psoriasis and Eczema |
See also...
Olux-E (clobetasol propionate) Consumer Information
Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
